XELMMIQ Trademark

Trademark Overview

On Wednesday, October 19, 2016, a trademark application was filed for XELMMIQ with the United States Patent and Trademark Office. The USPTO has given the XELMMIQ trademark a serial number of 87208607. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 23, 2020. This trademark is owned by Bristol-Myers Squibb Company. The XELMMIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
xelmmiq

General Information

Serial Number87208607
Word MarkXELMMIQ
Filing DateWednesday, October 19, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 23, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 25, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, November 23, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 23, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, April 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 24, 2020EXTENSION 5 GRANTED
Friday, April 17, 2020EXTENSION 5 FILED
Friday, April 24, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 17, 2020TEAS EXTENSION RECEIVED
Saturday, October 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 17, 2019EXTENSION 4 GRANTED
Thursday, October 17, 2019EXTENSION 4 FILED
Thursday, October 17, 2019TEAS EXTENSION RECEIVED
Saturday, March 30, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 28, 2019EXTENSION 3 GRANTED
Thursday, March 28, 2019EXTENSION 3 FILED
Thursday, March 28, 2019TEAS EXTENSION RECEIVED
Friday, October 19, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 17, 2018EXTENSION 2 GRANTED
Wednesday, October 17, 2018EXTENSION 2 FILED
Wednesday, October 17, 2018TEAS EXTENSION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 19, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 17, 2018EXTENSION 1 GRANTED
Tuesday, April 17, 2018EXTENSION 1 FILED
Tuesday, April 17, 2018TEAS EXTENSION RECEIVED
Tuesday, October 17, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 22, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 22, 2017PUBLISHED FOR OPPOSITION
Wednesday, August 2, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 13, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 12, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 11, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 11, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 13, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 13, 2017NON-FINAL ACTION E-MAILED
Friday, January 13, 2017NON-FINAL ACTION WRITTEN
Thursday, January 5, 2017ASSIGNED TO EXAMINER
Tuesday, October 25, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, October 22, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

xelmmiq diseases pharmaceutical human anti preparations disorders organ solid auto immune